HIDTA Enhancement Act
- Bill Number
- S. 767
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Crime and Law Enforcement
- Status
- Introduced
- Latest Action
- 2025-02-27: Read twice and referred to the Committee on the Judiciary.
- Last Updated
- 2026-01-10T07:28:21Z
AI-Generated Summary
Purpose
The HIDTA Enhancement Act (S. 767) aims to strengthen the U.S. government's efforts to combat fentanyl trafficking and related drug threats by updating reporting requirements, increasing funding, and providing additional prosecutorial resources for High Intensity Drug Trafficking Areas (HIDTAs). HIDTAs are designated regions where federal, state, local, and tribal agencies collaborate to disrupt drug trafficking.
Key Provisions
- Enhanced Reporting on Fentanyl Efforts: Requires the Office of National Drug Control Policy (ONDCP) to include in its annual reports details on HIDTA fund usage for investigating fentanyl trafficking organizations and individuals. This includes data on seized fentanyl amounts and regional threat assessments showing patterns in abuse, trafficking, and transportation.
- Assessments of HIDTA Limitations: Mandates that HIDTA directors evaluate any challenges in meeting program goals and provide recommendations, such as better resource allocation, partnerships, or legal changes.
- Increased Funding Authorization:
- Allocates $333,000,000 annually for HIDTA programs from fiscal years 2025 through 2030.
- Raises the authorization for the HIDTA Program Office from $10,000,000 to $14,224,000 per year.
- Expanded Program Purposes: Adds priorities for HIDTA activities, including support for law enforcement in intercepting (interdicting) fentanyl and other drugs, plus any other efforts the ONDCP Director deems necessary to improve prevention, seizure, and interdiction.
- Prosecutorial Resources: Directs the Attorney General to provide adequate investigative and prosecution support for HIDTAs, including temporary reassignment of Assistant United States Attorneys (AUSAs) from fiscal years 2024 through 2030. These AUSAs must prioritize fentanyl-related cases, with possible extensions for ongoing investigations. A process must be established within 180 days of enactment for ONDCP and HIDTA boards to request such reassignments.
Significant Changes to Existing Law
- Amends the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1701 et seq.) by adding fentanyl-specific reporting and assessment requirements, which were not previously detailed.
- Boosts funding levels beyond prior authorizations, providing sustained financial support through 2030.
- Introduces new prosecutorial mechanisms, including temporary AUSA reassignments and an formal request process, to address resource gaps in drug prosecutions.
- Broadens HIDTA purposes to explicitly target fentanyl interdiction, expanding from general drug trafficking focus.
Potential Impacts
- Government Agencies: Enhances coordination and resource allocation for ONDCP, the Department of Justice (DOJ), and HIDTA programs, potentially leading to more effective drug interdiction operations and higher prosecution rates for fentanyl cases.
- Citizens: Could reduce fentanyl availability in high-risk areas, lowering overdose deaths and related public health crises, though benefits depend on implementation.
- International Relations: May indirectly support U.S. efforts to pressure source countries (e.g., via seizures and intelligence sharing) but focuses primarily on domestic enforcement without direct foreign policy changes.
Main Stakeholders Affected
- Federal Agencies: ONDCP (leads reporting and coordination), DOJ/Attorney General (provides prosecutorial resources), and HIDTA Program Office (manages funding and activities).
- Law Enforcement: Federal, state, local, and tribal agencies involved in HIDTA initiatives, gaining better support for investigations and interdictions.
- Prosecutors: AUSAs, who may be reassigned to prioritize fentanyl cases, affecting DOJ workload distribution.
- Communities in HIDTAs: Residents in designated drug trafficking hotspots, potentially benefiting from reduced trafficking.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens existing anti-drug frameworks without creating new offenses; emphasizes resource efficiency and data-driven assessments, which could improve accountability in federal spending (e.g., under oversight laws like the Antideficiency Act).
- Constitutional: No apparent conflicts; aligns with Congress's spending power (Article I, Section 8) and executive enforcement authority, while respecting federalism by involving state and local partners.
- Political: Bipartisan sponsorship (from Senators Kelly, Capito, Blackburn, Cortez Masto, and Klobuchar) signals broad support for addressing the opioid crisis. It may influence future drug policy debates by prioritizing fentanyl, potentially setting precedents for targeted funding in public health emergencies.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (7)
Sen. Capito, Shelley Moore [R-WV], Sen. Blackburn, Marsha [R-TN], Sen. Cortez Masto, Catherine [D-NV], Sen. Klobuchar, Amy [D-MN], Sen. Sullivan, Dan [R-AK], Sen. Lankford, James [R-OK], Sen. Gallego, Ruben [D-AZ]
Recent Actions
- 2025-02-27: Read twice and referred to the Committee on the Judiciary.
- 2025-02-27: Introduced in Senate
Bill Versions
- HIDTA Enhancement Act — issued 2025-02-27 — PDF (5 pages)